Arnica

Materia Medica

Arnica

Arnica montana

Arnica is a yellow-flowered mountain daisy of Europe whose flower heads are made into gels, ointments and tinctures for bruises, sprains and sore muscles. It is used on unbroken skin only, because its sesquiterpene lactones, including helenalin, are toxic when swallowed.

What Is Arnica?

Arnica is a yellow-flowered mountain daisy whose flower heads are made into gels, ointments, oils and tinctures for bruises, sprains and sore muscles. It is used on unbroken skin only, because it is toxic when swallowed.

Arnica montana grows in montane to alpine grassland across continental Europe, up to about 3,000 m, on poor, acid soils 29Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →. The flower heads are the part used today, gathered at flowering and steeped in oil or alcohol 25,29Reference 25Battaglia · 2003The Complete Guide to Aromatherapy (2nd ed.)Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →.

Its main active constituents are sesquiterpene lactones, chiefly esters of helenalin and dihydrohelenalin 3,29Reference 3Lyss et al. · 1998In vitroThe anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-κB by directly targeting p65 — in vitroView study →Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →. Research on arnica is small and almost entirely topical. Its best results are in osteoarthritis of the hand and knee, where a gel matched ibuprofen gel in one trial 1,2Reference 1Widrig et al. · 2007RCTChoosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study — randomised, double-blindView study →Reference 2Knuesel et al. · 2002Clinical trialArnica montana gel in osteoarthritis of the knee: an open, multicenter clinical trial — clinical trialView study →.

Homeopathic arnica, an ultra-dilution taken by mouth, is a different preparation from the herbal gel, and trials of one do not apply to the other 16,18Reference 16Ernst et al. · 1998Systematic reviewEfficacy of homeopathic arnica: a systematic review of placebo-controlled clinical trials — systematic reviewView study →Reference 18Tao et al. · 2022ReviewHomeopathic agents or vitamins in reducing ecchymosis after oculofacial surgery: a report by the American Academy of Ophthalmology — reviewView study →.

How Is Arnica Used?

Arnica is applied to unbroken skin, over the bruise, sprain or sore muscle, two to four times a day 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →. It is never taken by mouth.

  • Ointments and gels — made with 20–25% arnica tincture, or 50% fresh-flower extract, in a cream or gel base 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →.
  • Tincture on a dressing — the tincture soaked into a compress and laid on the area 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →. The tincture is diluted before use 30Reference 30Committee on Herbal Medicinal Products · 2025ReviewEuropean Union herbal monograph on Arnica montana L., flos — draft revision 1 (EMA/HMPC/524586/2024)View study →.
  • Arnica oil — flower heads steeped in a fixed oil 25Reference 25Battaglia · 2003The Complete Guide to Aromatherapy (2nd ed.).

Traditional Uses

European Herbal Medicine

A herbal by Tabernaemontanus described arnica as a wound herb in 1613 31Reference 31Committee on Herbal Medicinal Products · 2014Assessment report on Arnica montana L., flos (EMA/HMPC/198794/2012)View study →. In the medieval period it was used for bruises and other injuries, varicose veins, phlebitis, gout, rheumatism, indigestion and heart disease 31Reference 31Committee on Herbal Medicinal Products · 2014Assessment report on Arnica montana L., flos (EMA/HMPC/198794/2012)View study →. Early twentieth-century herbals give the tincture externally for sprains, bruises and chilblains on unbroken skin, and note that it was seldom taken internally because it irritates the stomach 27Reference 27A Modern Herbal · 2016A Modern Herbal. (n.d.). Arnica. Retrieved August 13, 2016, from http://www.botanical.com/botanical/mgmh/a/arnic058.htmlView study →.

In Germany arnica has been used since 1957 for injuries such as bruises, sprains and haematomas, swelling after a fracture, rheumatic muscle and joint complaints, boils, insect-bite inflammation and superficial phlebitis 31Reference 31Committee on Herbal Medicinal Products · 2014Assessment report on Arnica montana L., flos (EMA/HMPC/198794/2012)View study →. The German Commission E monograph of 1984 covered much the same list, and restricted arnica to external use 23,31Reference 23Blumenthal · 1998ReviewThe Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicine — pharmacopoeial monograph (external use only)Reference 31Committee on Herbal Medicinal Products · 2014Assessment report on Arnica montana L., flos (EMA/HMPC/198794/2012)View study →.

Commission E’s traditional preparations are the tincture diluted three- to tenfold for compresses, an infusion of 2 g in 100 mL, an oil of one part flowers to five parts fixed oil, and ointments containing 20–25% tincture, all for unbroken skin 23Reference 23Blumenthal · 1998ReviewThe Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicine — pharmacopoeial monograph (external use only).

Homeopathy

Homeopathic arnica is an ultra-dilution taken by mouth, not a herbal preparation. It is given for a wider list than the herbal tincture, above all bruising, soreness and swelling after surgery or childbirth 16,17Reference 16Ernst et al. · 1998Systematic reviewEfficacy of homeopathic arnica: a systematic review of placebo-controlled clinical trials — systematic reviewView study →Reference 17Hart et al. · 1997RCTDouble-blind, placebo-controlled, randomised clinical trial of homoeopathic arnica C30 for pain and infection after total abdominal hysterectomy — randomisedView study →.

Placebo-controlled trials of the homeopathic preparation have largely found no effect 16,17,18Reference 16Ernst et al. · 1998Systematic reviewEfficacy of homeopathic arnica: a systematic review of placebo-controlled clinical trials — systematic reviewView study →Reference 17Hart et al. · 1997RCTDouble-blind, placebo-controlled, randomised clinical trial of homoeopathic arnica C30 for pain and infection after total abdominal hysterectomy — randomisedView study →Reference 18Tao et al. · 2022ReviewHomeopathic agents or vitamins in reducing ecchymosis after oculofacial surgery: a report by the American Academy of Ophthalmology — reviewView study →.

Indications

  • Bruises and haematomas [flower; topical] Caution: Trial results are mixed. A 20% arnica ointment cleared laser-induced bruises faster than petroleum jelly, but a lower-strength gel did no better than its base 5,6.
  • Sprains [flower; topical]
  • Localised muscle pain and soreness [flower; topical]
  • Osteoarthritis pain of the hand and knee [flower gel; topical]
  • Swelling after a fracture [flower; topical; Commission E]
  • Rheumatic muscle and joint complaints [flower; topical; Commission E]
  • Inflammation from insect bites [flower; topical]
  • Small boils (furuncles) [flower; topical]
  • Superficial phlebitis [flower; topical; Commission E]

Botany

Arnica is a herbaceous perennial in the daisy family (Asteraceae) 29Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →. It grows from a short, unbranched rhizome 29Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →.

Most of its leaves form a flat basal rosette. They are stalkless, ovate to lance-shaped and arranged in opposite pairs 29Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →. The leaves are downy 32Reference 32NC State Extension (n.d.)Arnica montana (leopard’s-bane)View study →.

An upright, sparsely branched stem rises 15–60 cm from the rosette and usually carries one to three bright yellow flower heads, each 6–8 cm across 29Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →. Each head has a centre of many small disc florets, surrounded by a single row of 11–15 (occasionally 20) ray florets 29Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →. It flowers from late spring into summer 32Reference 32NC State Extension (n.d.)Arnica montana (leopard’s-bane)View study →. The fruits carry a bristly, hairy pappus 32Reference 32NC State Extension (n.d.)Arnica montana (leopard’s-bane)View study →.

Distribution

Arnica montana is native to Europe. It grows north to northern France, Belgium, north-west Germany, Denmark and southern Norway, and east through Poland and the Baltic states 29Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →. In southern Europe it grows only at high altitude, in Portugal, northern and eastern Spain to the Pyrenees, northern Italy, the northern Balkans and southern Russia 29Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →. It is absent from Britain and Ireland 29Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →. Populations on the Iberian Peninsula are sometimes treated as a separate subspecies, subsp. atlantica 29Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →.

It is a plant of montane to alpine habitats up to about 3,000 m, on nutrient-poor, acid soils 29Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →. It also grows in meadows, pastures, heaths and open pine forest 32Reference 32NC State Extension (n.d.)Arnica montana (leopard’s-bane)View study →.

Arnica is protected under the EU Habitats Directive and is endangered in some regions, although the IUCN lists it as Least Concern at the European level 29Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →. Flower heads can still be collected from the wild in some areas 29Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →. The species is hard to farm, but a cultivar bred in the 1990s, ‘Arbo’, can be grown economically 4,29Reference 4Klaas et al. · 2002In vitroStudies on the anti-inflammatory activity of phytopharmaceuticals prepared from Arnica flowers — in vitro / animal model (mouse ear edema)View study →Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →.

For arnica products it is worth looking for cultivated material, such as ‘Arbo’, or asking how wild flowers were collected.

Growing Conditions

Cultivation snapshot for Arnica

LifeperennialZoneUSDA 4–9
  • Hardy mountain perennial, full sun to part shade.
  • Wants lime-free, well-drained soil 32Reference 32NC State Extension (n.d.)Arnica montana (leopard’s-bane)View study →.

Grow it yourself

Farm Wiki is our cultivation-focused sister site, also run by Justin Cooke.

How to growComing soon
Find seedsComing soon

Harvesting, Collection & Preparation

The flower heads are made into a macerated oil or a tincture for use on the skin 25Reference 25Battaglia · 2003The Complete Guide to Aromatherapy (2nd ed.).

Sesquiterpene lactones are richest in the disc florets (0.87%), followed by the ray florets (0.71%) and the receptacle (0.35%), with very little in the stems 21Reference 21Douglas et al. · 2004Sesquiterpene lactones in Arnica montana: a rapid analytical method and the effects of flower maturity and simulated mechanical harvesting on quality and yieldView study →. Total content rises as the flowers mature, from 0.51% in buds to 0.94% in withered flowers, so harvest timing affects potency 21Reference 21Douglas et al. · 2004Sesquiterpene lactones in Arnica montana: a rapid analytical method and the effects of flower maturity and simulated mechanical harvesting on quality and yieldView study →.

Pharmacology & Research

Arnica research is small and almost entirely topical 14,15Reference 14Smith et al. · 2021Clinical trialClinical trials, potential mechanisms, and adverse effects of Arnica as an adjunct medication for pain management — reviewView study →Reference 15Iannitti et al. · 2016ReviewEffectiveness and safety of Arnica montana in post-surgical setting, pain and inflammation — reviewView study →. Two osteoarthritis trials anchor it: an arnica tincture gel matched ibuprofen gel in 204 patients with hand osteoarthritis 1Reference 1Widrig et al. · 2007RCTChoosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study — randomised, double-blindView study →, and a fresh-plant gel improved WOMAC scores in an open knee-osteoarthritis study 2Reference 2Knuesel et al. · 2002Clinical trialArnica montana gel in osteoarthritis of the knee: an open, multicenter clinical trial — clinical trialView study →.

The antioxidant, antimicrobial, cholinesterase and anticancer findings rest on laboratory assays with no human data behind them 7,9,10,11,12,24Reference 7Craciunescu et al. · 2012In vitroEvaluation of antioxidant and cytoprotective activities of Arnica montana L. and Artemisia absinthium L. ethanolic extracts — in vitroView study →Reference 9Koo et al. · 2000In vitroIn vitro antimicrobial activity of propolis and Arnica montana against oral pathogens — in vitroView study →Reference 10Dirsch et al. · 2001In vitroHelenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-xL or Bcl-2 — in vitroView study →Reference 11Dirsch et al. · 2001In vitroCytotoxic sesquiterpene lactones mediate their death-inducing effect in leukemia T cells by triggering apoptosis — in vitroView study →Reference 12Lim et al. · 2012In vitroNF-κB p65 repression by the sesquiterpene lactone, helenalin, contributes to the induction of autophagy cell death — in vitroView study →Reference 24Zheleva-Dimitrova et al. · 2012In vitroAntioxidant and acetylcholinesterase inhibitory potential of Arnica montana cultivated in Bulgaria — in vitroView study →. The anticancer work used isolated helenalin.

What the Evidence Supports
  • Best-supported: symptomatic osteoarthritis relief from a topical gel, non-inferior to ibuprofen gel over 3 weeks 1,2Reference 1Widrig et al. · 2007RCTChoosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study — randomised, double-blindView study →Reference 2Knuesel et al. · 2002Clinical trialArnica montana gel in osteoarthritis of the knee: an open, multicenter clinical trial — clinical trialView study →; anti-inflammatory action with a defined NF-κB mechanism 3,4Reference 3Lyss et al. · 1998In vitroThe anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-κB by directly targeting p65 — in vitroView study →Reference 4Klaas et al. · 2002In vitroStudies on the anti-inflammatory activity of phytopharmaceuticals prepared from Arnica flowers — in vitro / animal model (mouse ear edema)View study →.
  • Emerging, worth watching: faster resolution of laser-induced bruising with a high-concentration (20%) topical 5Reference 5Leu et al. · 2010RCTAccelerated resolution of laser-induced bruising with topical 20% arnica: a rater-blinded randomised controlled trial — randomisedView study →; less muscle tenderness after eccentric exercise 8Reference 8Pumpa et al. · 2014RCTThe effects of topical Arnica on performance, pain and muscle damage after intense eccentric exercise — randomised, placebo-controlledView study →.
  • Mechanistically thin: antioxidant, antimicrobial and anticancer signals rest on cell and test-tube work or on isolated helenalin 7,9,10,11,12Reference 7Craciunescu et al. · 2012In vitroEvaluation of antioxidant and cytoprotective activities of Arnica montana L. and Artemisia absinthium L. ethanolic extracts — in vitroView study →Reference 9Koo et al. · 2000In vitroIn vitro antimicrobial activity of propolis and Arnica montana against oral pathogens — in vitroView study →Reference 10Dirsch et al. · 2001In vitroHelenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-xL or Bcl-2 — in vitroView study →Reference 11Dirsch et al. · 2001In vitroCytotoxic sesquiterpene lactones mediate their death-inducing effect in leukemia T cells by triggering apoptosis — in vitroView study →Reference 12Lim et al. · 2012In vitroNF-κB p65 repression by the sesquiterpene lactone, helenalin, contributes to the induction of autophagy cell death — in vitroView study →.
  • The caveat: herbal (topical) arnica and homeopathic (ultra-dilute) arnica are different things. The large post-surgical and bruising trial literature is homeopathic and largely null 16,17,18Reference 16Ernst et al. · 1998Systematic reviewEfficacy of homeopathic arnica: a systematic review of placebo-controlled clinical trials — systematic reviewView study →Reference 17Hart et al. · 1997RCTDouble-blind, placebo-controlled, randomised clinical trial of homoeopathic arnica C30 for pain and infection after total abdominal hysterectomy — randomisedView study →Reference 18Tao et al. · 2022ReviewHomeopathic agents or vitamins in reducing ecchymosis after oculofacial surgery: a report by the American Academy of Ophthalmology — reviewView study →, and does not transfer to the gel.

No placebo-controlled trial of topical arnica in osteoarthritis exists. The best result is non-inferiority to a topical ibuprofen gel, so the effect against no treatment has not been measured 1,2Reference 1Widrig et al. · 2007RCTChoosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study — randomised, double-blindView study →Reference 2Knuesel et al. · 2002Clinical trialArnica montana gel in osteoarthritis of the knee: an open, multicenter clinical trial — clinical trialView study →.

Evidence by IndicationStrength of support
68%
AntioxidantPromising
50%
30%
1. Osteoarthritis (Topical)

A randomised, double-blind trial in 204 patients with radiologically confirmed hand osteoarthritis found an arnica tincture gel (50 g tincture per 100 g, DER 1:20) not inferior to 5% ibuprofen gel for pain and hand function over 21 days 1Reference 1Widrig et al. · 2007RCTChoosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study — randomised, double-blindView study →. Adverse events were similar (4.8% on arnica, 6.1% on ibuprofen) 1Reference 1Widrig et al. · 2007RCTChoosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study — randomised, double-blindView study →.

An open, multicentre study of a fresh-plant arnica gel, applied twice daily in 79 patients with mild to moderate knee osteoarthritis, reported significant improvements in WOMAC pain, stiffness and function scores at 3 and 6 weeks 2Reference 2Knuesel et al. · 2002Clinical trialArnica montana gel in osteoarthritis of the knee: an open, multicenter clinical trial — clinical trialView study →. The local adverse-event rate was 7.6%, with one allergic reaction 2Reference 2Knuesel et al. · 2002Clinical trialArnica montana gel in osteoarthritis of the knee: an open, multicenter clinical trial — clinical trialView study →.

One trial was an active-comparator non-inferiority study and the other was uncontrolled.

Gap: no placebo-controlled RCT of topical arnica in osteoarthritis exists, and the comparator in the one controlled trial was itself a topical gel.

2. Anti-Inflammatory

The sesquiterpene lactone helenalin inhibits the transcription factor NF-κB. It does this not by blocking IκB degradation, as older models proposed, but by alkylating the p65 subunit directly 3Reference 3Lyss et al. · 1998In vitroThe anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-κB by directly targeting p65 — in vitroView study →.

Arnica flower preparations suppress NF-κB and NF-AT activation and reduce croton-oil ear swelling in mice 4Reference 4Klaas et al. · 2002In vitroStudies on the anti-inflammatory activity of phytopharmaceuticals prepared from Arnica flowers — in vitro / animal model (mouse ear edema)View study →. Their potency follows their sesquiterpene-lactone content, and the esters of dihydrohelenalin with unsaturated acids are more active than its acetate 4Reference 4Klaas et al. · 2002In vitroStudies on the anti-inflammatory activity of phytopharmaceuticals prepared from Arnica flowers — in vitro / animal model (mouse ear edema)View study →. The lactones permeate the outer layer of the skin from tinctures and fresh-plant preparations, much more than the isolated compounds do 19Reference 19Wagner et al. · 2004In vitroSkin penetration studies of Arnica preparations and of their sesquiterpene lactones — in vitroView study →.

The material varies. Spanish populations include both helenalin-rich and dihydrohelenalin-rich chemotypes 20Reference 20Perry et al. · 2009Sesquiterpene lactones in Arnica montana: helenalin and dihydrohelenalin chemotypes in SpainView study →, and total lactone content rises as the flowers mature and is highest in the disc florets 21Reference 21Douglas et al. · 2004Sesquiterpene lactones in Arnica montana: a rapid analytical method and the effects of flower maturity and simulated mechanical harvesting on quality and yieldView study →. A tincture of the helenalin chemotype inhibited NF-κB about twice as strongly as one of the dihydrohelenalin chemotype 29Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →.

The human osteoarthritis and muscle-soreness results are the clinical read-out of this pathway. No human trial has measured an inflammatory biomarker.

3. Bruising & Ecchymosis

Results are mixed, and concentration may be the reason.

A rater-blinded RCT using standardised pulsed-dye-laser bruises found a 20% arnica ointment, applied twice daily under occlusion for two weeks, improved bruising more than white petrolatum and more than a 1% vitamin K and retinol mix, though not more than 5% vitamin K 5Reference 5Leu et al. · 2010RCTAccelerated resolution of laser-induced bruising with topical 20% arnica: a rater-blinded randomised controlled trial — randomisedView study →.

A double-blind, placebo-controlled trial of an arnica gel in 19 patients with post-laser facial bruising found no difference from its base 6Reference 6Alonso et al. · 2002RCTEffects of topical arnica gel on post-laser treatment bruises — randomised, placebo-controlledView study →. A 2022 American Academy of Ophthalmology review found that in seven controlled studies, oral or topical arnica gave no or negligible benefit for bruising after eyelid, facial or laser surgery 18Reference 18Tao et al. · 2022ReviewHomeopathic agents or vitamins in reducing ecchymosis after oculofacial surgery: a report by the American Academy of Ophthalmology — reviewView study →.

Gap: the positive result comes from a high-concentration (20%) topical. Lower-strength gels have failed, and no trial has standardised the preparation.

4. Antioxidant

An ethanolic extract of arnica flowers, rich in phenolics and flavonoids, scavenged free radicals in DPPH, ORAC and Trolox-equivalent assays 7Reference 7Craciunescu et al. · 2012In vitroEvaluation of antioxidant and cytoprotective activities of Arnica montana L. and Artemisia absinthium L. ethanolic extracts — in vitroView study →. In a mouse fibroblast (NCTC) cell line it protected cells against hydrogen-peroxide damage, best at 10 mg/L 7Reference 7Craciunescu et al. · 2012In vitroEvaluation of antioxidant and cytoprotective activities of Arnica montana L. and Artemisia absinthium L. ethanolic extracts — in vitroView study →. The extract was rich in quercetin, rutin and apigenin 7Reference 7Craciunescu et al. · 2012In vitroEvaluation of antioxidant and cytoprotective activities of Arnica montana L. and Artemisia absinthium L. ethanolic extracts — in vitroView study →.

This is a single cell line with no human outcome, and a wormwood (Artemisia absinthium) extract was more strongly antioxidant in the same assays 7Reference 7Craciunescu et al. · 2012In vitroEvaluation of antioxidant and cytoprotective activities of Arnica montana L. and Artemisia absinthium L. ethanolic extracts — in vitroView study →.

5. Muscle Soreness (DOMS)

A double-blind, randomised, placebo-controlled trial tested topical arnica in 20 well-trained men after a downhill run designed to cause delayed-onset muscle soreness, reapplied every 4 waking hours 8Reference 8Pumpa et al. · 2014RCTThe effects of topical Arnica on performance, pain and muscle damage after intense eccentric exercise — randomised, placebo-controlledView study →. The arnica group reported less pain, on both a visual analogue scale and muscle tenderness, at 72 hours after exercise 8Reference 8Pumpa et al. · 2014RCTThe effects of topical Arnica on performance, pain and muscle damage after intense eccentric exercise — randomised, placebo-controlledView study →.

Arnica changed no performance measure (peak torque, jump height) and no blood marker of muscle damage or inflammation (creatine kinase, myoglobin, IL-1β, IL-6, TNF-α, CRP) 8Reference 8Pumpa et al. · 2014RCTThe effects of topical Arnica on performance, pain and muscle damage after intense eccentric exercise — randomised, placebo-controlledView study →.

6. Antimicrobial

A 10% w/v Arnica montana extract was tested by agar diffusion against 15 oral micro-organisms, alongside propolis 9Reference 9Koo et al. · 2000In vitroIn vitro antimicrobial activity of propolis and Arnica montana against oral pathogens — in vitroView study →. The arnica extract showed no significant antimicrobial activity 9Reference 9Koo et al. · 2000In vitroIn vitro antimicrobial activity of propolis and Arnica montana against oral pathogens — in vitroView study →. It slightly reduced the adherence of Streptococcus mutans (19%) and S. sobrinus (15%) and the formation of insoluble glucan (29%), where propolis inhibited all three strongly 9Reference 9Koo et al. · 2000In vitroIn vitro antimicrobial activity of propolis and Arnica montana against oral pathogens — in vitroView study →.

Reviews list antibacterial and antifungal activity as a property of arnica extracts 13Reference 13Kriplani et al. · 2017ReviewArnica montana L. — a plant of healing: review — reviewView study →. There is no infection model and no clinical antimicrobial use.

7. Anticancer

Purified helenalin induces apoptosis in leukaemia (Jurkat) T cells at 10–50 µM through caspase-3 and -8 activation. The effect does not depend on the CD95 death receptor and is not blocked by Bcl-2 or Bcl-xL overexpression 10Reference 10Dirsch et al. · 2001In vitroHelenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-xL or Bcl-2 — in vitroView study →. Related sesquiterpene lactones share this property 11Reference 11Dirsch et al. · 2001In vitroCytotoxic sesquiterpene lactones mediate their death-inducing effect in leukemia T cells by triggering apoptosis — in vitroView study →.

The same NF-κB p65 repression behind the anti-inflammatory action also triggers autophagic cell death in cancer cells 12Reference 12Lim et al. · 2012In vitroNF-κB p65 repression by the sesquiterpene lactone, helenalin, contributes to the induction of autophagy cell death — in vitroView study →.

Helenalin is toxic taken internally, and arnica is used only on intact skin 22,23Reference 22Cosmetic Ingredient Review Expert Panel · 2001ReviewFinal report on the safety assessment of Arnica montana extract and Arnica montanaView study →Reference 23Blumenthal · 1998ReviewThe Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicine — pharmacopoeial monograph (external use only).

Gap: cell-line only, at micromolar concentrations of an isolated toxic constituent. There is no whole-herb, animal or clinical anticancer evidence.

8. Cholinesterase Inhibition

A methanolic extract of Arnica montana flower heads showed moderate anti-acetylcholinesterase activity in vitro, alongside antioxidant capacity 24Reference 24Zheleva-Dimitrova et al. · 2012In vitroAntioxidant and acetylcholinesterase inhibitory potential of Arnica montana cultivated in Bulgaria — in vitroView study →. Cholinesterase inhibitors are used for the symptoms of Alzheimer’s disease.

Gap: one enzyme assay, with no animal or clinical follow-up.

Mechanisms

The sesquiterpene lactones, chiefly helenalin, alkylate the p65 subunit of NF-κB directly and block its binding to DNA 3Reference 3Lyss et al. · 1998In vitroThe anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-κB by directly targeting p65 — in vitroView study →. This has been studied as the basis of the anti-inflammatory effect and of the cell-line anticancer work 3,4,12Reference 3Lyss et al. · 1998In vitroThe anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-κB by directly targeting p65 — in vitroView study →Reference 4Klaas et al. · 2002In vitroStudies on the anti-inflammatory activity of phytopharmaceuticals prepared from Arnica flowers — in vitro / animal model (mouse ear edema)View study →Reference 12Lim et al. · 2012In vitroNF-κB p65 repression by the sesquiterpene lactone, helenalin, contributes to the induction of autophagy cell death — in vitroView study →.

The flavonoids have been studied for antioxidant activity, and a whole extract for cholinesterase inhibition, both in the laboratory only 7,24Reference 7Craciunescu et al. · 2012In vitroEvaluation of antioxidant and cytoprotective activities of Arnica montana L. and Artemisia absinthium L. ethanolic extracts — in vitroView study →Reference 24Zheleva-Dimitrova et al. · 2012In vitroAntioxidant and acetylcholinesterase inhibitory potential of Arnica montana cultivated in Bulgaria — in vitroView study →.

MechanismDrivesKey compounds
NF-κB p65 alkylation (direct DNA-binding block)
anti-inflammatoryanticancer
helenalin, dihydrohelenalin
NF-κB and NF-AT inhibition, croton-oil edema ↓
anti-inflammatory
helenalin and dihydrohelenalin esters
Free-radical scavenging (phenolic/flavonoid)
antioxidant
quercetin, rutin
Caspase-3/-8 activation, autophagy induction
anticancer (in vitro)
helenalin
Acetylcholinesterase inhibition (in vitro)
cholinesterase inhibition
— (whole extract)

Clinical Trials

Published human trials of topical herbal arnica are few (osteoarthritis, laser bruising, muscle soreness). The much larger post-surgical and bruising trial literature tests homeopathic ultra-dilutions and is a separate, largely null body of evidence 16,17,18Reference 16Ernst et al. · 1998Systematic reviewEfficacy of homeopathic arnica: a systematic review of placebo-controlled clinical trials — systematic reviewView study →Reference 17Hart et al. · 1997RCTDouble-blind, placebo-controlled, randomised clinical trial of homoeopathic arnica C30 for pain and infection after total abdominal hysterectomy — randomisedView study →Reference 18Tao et al. · 2022ReviewHomeopathic agents or vitamins in reducing ecchymosis after oculofacial surgery: a report by the American Academy of Ophthalmology — reviewView study →.

CompletedPlannedTerminatedPreclinical
~5(topical herbal)00~30+

Last checked: July 2026.

Phytochemistry

Arnica flowers contain sesquiterpene lactones of the pseudoguaianolide type, chiefly helenalin and 11α,13-dihydrohelenalin 29Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →. They occur mostly as esters with acetic, isobutyric, methacrylic, methylbutyric and tiglic acids, with small amounts of the free parent compounds 29Reference 29Schmidt · 2023ReviewArnica montana L.: doesn’t origin matter? — reviewView study →. These lactones carry the anti-inflammatory activity and are also the chief toxic constituents 3,22Reference 3Lyss et al. · 1998In vitroThe anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-κB by directly targeting p65 — in vitroView study →Reference 22Cosmetic Ingredient Review Expert Panel · 2001ReviewFinal report on the safety assessment of Arnica montana extract and Arnica montanaView study →.

Total sesquiterpene lactones vary naturally from 0.3 to 1.0% of the dried flower, and the European Pharmacopoeia requires at least 0.4% 31Reference 31Committee on Herbal Medicinal Products · 2014Assessment report on Arnica montana L., flos (EMA/HMPC/198794/2012)View study →. The balance between the two main types varies. In Spain, high-altitude heathland populations held 5.2–10.3 mg/g of helenalins, while lower meadow and bog populations held 10.9–18.2 mg/g of dihydrohelenalins 20Reference 20Perry et al. · 2009Sesquiterpene lactones in Arnica montana: helenalin and dihydrohelenalin chemotypes in SpainView study →.

The flowers also contain flavonoids (0.4–0.6%) and an essential oil (0.2–0.35%) 31Reference 31Committee on Herbal Medicinal Products · 2014Assessment report on Arnica montana L., flos (EMA/HMPC/198794/2012)View study →. In one ethanolic flower extract, quercetin (1.88 mg/g) and rutin (1.19 mg/g) were the main flavonoids 7Reference 7Craciunescu et al. · 2012In vitroEvaluation of antioxidant and cytoprotective activities of Arnica montana L. and Artemisia absinthium L. ethanolic extracts — in vitroView study →. Coumarins, the bitter principle arnicin, inulin and phytosterols are also reported 22,27Reference 22Cosmetic Ingredient Review Expert Panel · 2001ReviewFinal report on the safety assessment of Arnica montana extract and Arnica montanaView study →Reference 27A Modern Herbal · 2016A Modern Herbal. (n.d.). Arnica. Retrieved August 13, 2016, from http://www.botanical.com/botanical/mgmh/a/arnic058.htmlView study →.

Constituent Summary

Amounts are for dried flower heads unless stated.

Grouped by class · 12 compounds
Sesquiterpene Lactone3 compounds3 with data
Sesquiterpene LactoneHelenalin5.2–10.3 mg/g (helenalin chemotype) 20Reference 20Perry et al. · 2009Sesquiterpene lactones in Arnica montana: helenalin and dihydrohelenalin chemotypes in SpainView study →
Sesquiterpene LactoneDihydrohelenalin10.9–18.2 mg/g (dihydrohelenalin chemotype) 20Reference 20Perry et al. · 2009Sesquiterpene lactones in Arnica montana: helenalin and dihydrohelenalin chemotypes in SpainView study →
Sesquiterpene LactoneSesquiterpene lactones0.3–1.0% total 31Reference 31Committee on Herbal Medicinal Products · 2014Assessment report on Arnica montana L., flos (EMA/HMPC/198794/2012)View study →
Flavonoid5 compounds3 with data
FlavonoidQuercetin1.88 mg/g dry extract 7Reference 7Craciunescu et al. · 2012In vitroEvaluation of antioxidant and cytoprotective activities of Arnica montana L. and Artemisia absinthium L. ethanolic extracts — in vitroView study →
FlavonoidIsoquercitrinNo data
FlavonoidAstragalinNo data
FlavonoidRutin1.19 mg/g dry extract 7Reference 7Craciunescu et al. · 2012In vitroEvaluation of antioxidant and cytoprotective activities of Arnica montana L. and Artemisia absinthium L. ethanolic extracts — in vitroView study →
FlavonoidFlavonoids0.4–0.6% total 31Reference 31Committee on Herbal Medicinal Products · 2014Assessment report on Arnica montana L., flos (EMA/HMPC/198794/2012)View study →
Monoterpene1 compoundno data
MonoterpeneThymolNo data
Coumarin1 compoundno data
CoumarinCoumarinsNo data
Terpenoid1 compoundno data
TerpenoidArnicinNo data
Fructan1 compoundno data
FructanInulinNo data

Dosage

Arnica is used only on the skin, and never by mouth. The research preparations are mostly proprietary or fresh-plant gels without a stated marker content, so no dried-herb equivalent can be given for most of them.

Research Doses

IndicationPreparationDoseEst. dried-herb equivalentSource
Hand osteoarthritisArnica tincture gel, 50 g tincture/100 g (DER 1:20)applied topically over 21 daysNot quantified1Reference 1Widrig et al. · 2007RCTChoosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study — randomised, double-blindView study →
Knee osteoarthritisFresh-plant arnica geltwice daily, for 6 weeksNot quantified2Reference 2Knuesel et al. · 2002Clinical trialArnica montana gel in osteoarthritis of the knee: an open, multicenter clinical trial — clinical trialView study →
Laser bruising20% arnica ointmenttwice daily under occlusion, 2 weeksNot quantified5Reference 5Leu et al. · 2010RCTAccelerated resolution of laser-induced bruising with topical 20% arnica: a rater-blinded randomised controlled trial — randomisedView study →
Muscle soreness (DOMS)Topical arnica preparationevery 4 waking hours after exerciseNot quantified8Reference 8Pumpa et al. · 2014RCTThe effects of topical Arnica on performance, pain and muscle damage after intense eccentric exercise — randomised, placebo-controlledView study →

Traditional Dosage

The EU herbal monograph covers these preparations for adults and adolescents, applied to unbroken skin 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →.

SystemPreparationDose
EU herbal monographOintment or gel with 20–25% tinctureThin layer, 2–3 times daily 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →
EU herbal monographTincture, 2.5 mL on a dressingApplied 3–4 times daily 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →
EU herbal monographGel with 50% fresh-flower liquid extractThin layer, 2–4 times daily 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →
Commission ETincture diluted 3–10× for compresses; or infusion 2 g/100 mLTopical, unbroken skin only 23Reference 23Blumenthal · 1998ReviewThe Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicine — pharmacopoeial monograph (external use only)
Commission EArnica oil (1 part flowers : 5 parts fixed oil)Topical, unbroken skin only 23Reference 23Blumenthal · 1998ReviewThe Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicine — pharmacopoeial monograph (external use only)

If symptoms last longer than 3–4 days, a doctor or qualified practitioner should be consulted 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →.

Safety & Pregnancy

Arnica is used only on unbroken skin. Taken by mouth it is toxic, and allergy to the daisy family is its most common side effect on the skin.

Safety at a Glance
ToxicDaisy-family allergy
  • Never take it by mouth. Swallowed arnica products have caused severe gastroenteritis, nervousness, a racing heart, muscle weakness and death 22Reference 22Cosmetic Ingredient Review Expert Panel · 2001ReviewFinal report on the safety assessment of Arnica montana extract and Arnica montanaView study →.
  • Not on broken skin. Keep it off open wounds, and away from the eyes and mucous membranes 28,30Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →Reference 30Committee on Herbal Medicinal Products · 2025ReviewEuropean Union herbal monograph on Arnica montana L., flos — draft revision 1 (EMA/HMPC/524586/2024)View study →.
  • Pregnancy and breastfeeding. Not recommended, even on the skin, because safety has not been established 28,30Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →Reference 30Committee on Herbal Medicinal Products · 2025ReviewEuropean Union herbal monograph on Arnica montana L., flos — draft revision 1 (EMA/HMPC/524586/2024)View study →.
  • Children. The EU monograph does not recommend it under 12 years of age 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →.
  • Daisy-family allergy. Do not use if allergic to arnica or other Asteraceae; it can cause itching, redness and eczema 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →.
  • Homeopathic arnica is different. Ultra-dilute homeopathic arnica is a separate preparation not covered here.
Full Safety & Interactions Detail

Internal use. Arnica must not be taken by mouth. Swallowed arnica products have caused severe gastroenteritis, nervousness, a fast heart rate, muscle weakness and death 22Reference 22Cosmetic Ingredient Review Expert Panel · 2001ReviewFinal report on the safety assessment of Arnica montana extract and Arnica montanaView study →. Heart-rhythm disturbance and organ damage have also been attributed to helenalin taken internally. Commission E and the EU monograph limit arnica to use on the skin 23,28,31Reference 23Blumenthal · 1998ReviewThe Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicine — pharmacopoeial monograph (external use only)Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →Reference 31Committee on Herbal Medicinal Products · 2014Assessment report on Arnica montana L., flos (EMA/HMPC/198794/2012)View study →.

Broken skin, eyes and mucous membranes. Arnica should not be used on broken skin 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →. The EU monograph’s draft revision adds that it should not be applied near the eyes or mucous membranes, and that the tincture should be diluted before use 30Reference 30Committee on Herbal Medicinal Products · 2025ReviewEuropean Union herbal monograph on Arnica montana L., flos — draft revision 1 (EMA/HMPC/524586/2024)View study →. The lactones pass into the outer layer of the skin from tinctures and gels 19Reference 19Wagner et al. · 2004In vitroSkin penetration studies of Arnica preparations and of their sesquiterpene lactones — in vitroView study →.

Allergy. Arnica is contraindicated in people allergic to it or to other members of the daisy family (Asteraceae) 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →. Allergic reactions such as itching, redness and eczema can occur 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →. Allergic contact dermatitis is well known, but given how widely arnica is used, contact allergy is relatively uncommon 31Reference 31Committee on Herbal Medicinal Products · 2014Assessment report on Arnica montana L., flos (EMA/HMPC/198794/2012)View study →. Prolonged or repeated use raises the risk 22Reference 22Cosmetic Ingredient Review Expert Panel · 2001ReviewFinal report on the safety assessment of Arnica montana extract and Arnica montanaView study →.

Children. The 2014 EU monograph does not recommend arnica under 12 years of age for lack of data 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →. The draft revision keeps this for some preparations and lowers it to 3 years for others 30Reference 30Committee on Herbal Medicinal Products · 2025ReviewEuropean Union herbal monograph on Arnica montana L., flos — draft revision 1 (EMA/HMPC/524586/2024)View study →.

Duration. If symptoms worsen, or last longer than 3–4 days, a doctor or qualified practitioner should be consulted 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →. For insect bites and boils, fever or a spreading skin infection is a reason to seek care, and boils on the face should be treated by a doctor 30Reference 30Committee on Herbal Medicinal Products · 2025ReviewEuropean Union herbal monograph on Arnica montana L., flos — draft revision 1 (EMA/HMPC/524586/2024)View study →.

Interactions. None have been reported 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →.

Homeopathic arnica. Homeopathic ultra-dilutions are a separate preparation and are not covered by these cautions.

Pregnancy & Lactation
Avoid in pregnancy Avoid while breastfeeding

Avoid. Arnica is toxic taken internally and must never be swallowed in pregnancy 22,23Reference 22Cosmetic Ingredient Review Expert Panel · 2001ReviewFinal report on the safety assessment of Arnica montana extract and Arnica montanaView study →Reference 23Blumenthal · 1998ReviewThe Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicine — pharmacopoeial monograph (external use only).

The EU herbal monograph does not recommend topical arnica in pregnancy either, because its safety has not been established 28Reference 28Committee on Herbal Medicinal Products · 2014ReviewCommunity herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monographView study →. The 2025 draft revision extends this to breastfeeding 30Reference 30Committee on Herbal Medicinal Products · 2025ReviewEuropean Union herbal monograph on Arnica montana L., flos — draft revision 1 (EMA/HMPC/524586/2024)View study →.

Do not apply it to the breast area while breastfeeding.

References

  1. Widrig, R., Suter, A., Saller, R., & Melzer, J. (2007). Choosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study — randomised, double-blind. Rheumatology International. https://pubmed.ncbi.nlm.nih.gov/17318618/
  2. Knuesel, O., Weber, M., & Suter, A. (2002). Arnica montana gel in osteoarthritis of the knee: an open, multicenter clinical trial — clinical trial. Advances in Therapy. https://pubmed.ncbi.nlm.nih.gov/12539881/
  3. Lyss, G., Knorre, A., Schmidt, T. J., Pahl, H. L., & Merfort, I. (1998). The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-κB by directly targeting p65 — in vitro. Journal of Biological Chemistry. https://pubmed.ncbi.nlm.nih.gov/9837931/
  4. Klaas, C. A., Wagner, G., Laufer, S., et al. (2002). Studies on the anti-inflammatory activity of phytopharmaceuticals prepared from Arnica flowers — in vitro / animal model (mouse ear edema). Planta Medica. https://pubmed.ncbi.nlm.nih.gov/12058311/
  5. Leu, S., Havey, J., White, L. E., et al. (2010). Accelerated resolution of laser-induced bruising with topical 20% arnica: a rater-blinded randomised controlled trial — randomised. British Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov/20412090/
  6. Alonso, D., Lazarus, M. C., & Baumann, L. (2002). Effects of topical arnica gel on post-laser treatment bruises — randomised, placebo-controlled. Dermatologic Surgery. https://pubmed.ncbi.nlm.nih.gov/12174058/
  7. Craciunescu, O., Constantin, D., Gaspar, A., et al. (2012). Evaluation of antioxidant and cytoprotective activities of Arnica montana L. and Artemisia absinthium L. ethanolic extracts — in vitro. Chemistry Central Journal. https://pubmed.ncbi.nlm.nih.gov/22958433/
  8. Pumpa, K. L., Fallon, K. E., Bensoussan, A., & Papalia, S. (2014). The effects of topical Arnica on performance, pain and muscle damage after intense eccentric exercise — randomised, placebo-controlled. European Journal of Sport Science. https://pubmed.ncbi.nlm.nih.gov/23947690/
  9. Koo, H., Gomes, B. P., Rosalen, P. L., et al. (2000). In vitro antimicrobial activity of propolis and Arnica montana against oral pathogens — in vitro. Archives of Oral Biology. https://pubmed.ncbi.nlm.nih.gov/10716618/
  10. Dirsch, V. M., Stuppner, H., & Vollmar, A. M. (2001). Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-xL or Bcl-2 — in vitro. Cancer Research. https://pubmed.ncbi.nlm.nih.gov/11479221/
  11. Dirsch, V. M., Stuppner, H., & Vollmar, A. M. (2001). Cytotoxic sesquiterpene lactones mediate their death-inducing effect in leukemia T cells by triggering apoptosis — in vitro. Planta Medica. https://pubmed.ncbi.nlm.nih.gov/11509981/
  12. Lim, C. B., Fu, P. Y., Ky, N., et al. (2012). NF-κB p65 repression by the sesquiterpene lactone, helenalin, contributes to the induction of autophagy cell death — in vitro. BMC Complementary and Alternative Medicine. https://pubmed.ncbi.nlm.nih.gov/22784363/
  13. Kriplani, P., Guarve, K., & Baghael, U. S. (2017). Arnica montana L. — a plant of healing: review — review. Journal of Pharmacy and Pharmacology. https://pubmed.ncbi.nlm.nih.gov/28401567/
  14. Smith, A. G., Miles, V. N., Holmes, D. T., et al. (2021). Clinical trials, potential mechanisms, and adverse effects of Arnica as an adjunct medication for pain management — review. Medicines (Basel). https://pubmed.ncbi.nlm.nih.gov/34677487/
  15. Iannitti, T., Morales-Medina, J. C., Bellavite, P., et al. (2016). Effectiveness and safety of Arnica montana in post-surgical setting, pain and inflammation — review. American Journal of Therapeutics. https://pubmed.ncbi.nlm.nih.gov/25171757/
  16. Ernst, E., & Pittler, M. H. (1998). Efficacy of homeopathic arnica: a systematic review of placebo-controlled clinical trials — systematic review. Archives of Surgery. https://pubmed.ncbi.nlm.nih.gov/9820349/
  17. Hart, O., Mullee, M. A., Lewith, G., & Miller, J. (1997). Double-blind, placebo-controlled, randomised clinical trial of homoeopathic arnica C30 for pain and infection after total abdominal hysterectomy — randomised. Journal of the Royal Society of Medicine. https://pubmed.ncbi.nlm.nih.gov/9068434/
  18. Tao, J. P., Aakalu, V. K., Wladis, E. J., et al. (2022). Homeopathic agents or vitamins in reducing ecchymosis after oculofacial surgery: a report by the American Academy of Ophthalmology — review. Ophthalmology. https://pubmed.ncbi.nlm.nih.gov/34176651/
  19. Wagner, S., & Merfort, I. (2004). Skin penetration studies of Arnica preparations and of their sesquiterpene lactones — in vitro. Planta Medica. https://pubmed.ncbi.nlm.nih.gov/15490315/
  20. Perry, N. B., Burgess, E. J., Rodríguez Guitián, M. A., et al. (2009). Sesquiterpene lactones in Arnica montana: helenalin and dihydrohelenalin chemotypes in Spain. Planta Medica. https://pubmed.ncbi.nlm.nih.gov/19235681/
  21. Douglas, J. A., Smallfield, B. M., Burgess, E. J., et al. (2004). Sesquiterpene lactones in Arnica montana: a rapid analytical method and the effects of flower maturity and simulated mechanical harvesting on quality and yield. Planta Medica. https://pubmed.ncbi.nlm.nih.gov/14994196/
  22. Cosmetic Ingredient Review Expert Panel. (2001). Final report on the safety assessment of Arnica montana extract and Arnica montana. International Journal of Toxicology. https://doi.org/10.1080/10915810160233712
  23. Blumenthal, M. (Ed.). (1998). The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicine — pharmacopoeial monograph (external use only). American Botanical Council.
  24. Zheleva-Dimitrova, D., & Balabanova, V. (2012). Antioxidant and acetylcholinesterase inhibitory potential of Arnica montana cultivated in Bulgaria — in vitro. Turkish Journal of Biology, 36, 732-737. https://doi.org/10.3906/biy-1204-70
  25. Battaglia, S. (2003). The Complete Guide to Aromatherapy (2nd ed.). Brisbane, Australia: The International Centre of Holistic Aromatherapy. (Pg 313)
  26. Wijnsma, R., Woerdenbag, H. J., & Busse, W. (1995). The importance of Arnica species in phytomedicine. Zeitschrift für Phytotherapie, 16, 48–62.
  27. A Modern Herbal. (n.d.). Arnica. Retrieved August 13, 2016, from http://www.botanical.com/botanical/mgmh/a/arnic058.html
  28. Committee on Herbal Medicinal Products (2014). Community herbal monograph on Arnica montana L., flos (EMA/HMPC/198793/2012) — pharmacopoeial monograph. European Medicines Agency. https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-arnica-montana-l-flos_en.pdf
  29. Schmidt, T. J. (2023). Arnica montana L.: doesn’t origin matter? — review. Plants, 12(20), 3532. https://pubmed.ncbi.nlm.nih.gov/37895999/
  30. Committee on Herbal Medicinal Products (2025). European Union herbal monograph on Arnica montana L., flos — draft revision 1 (EMA/HMPC/524586/2024). European Medicines Agency. https://www.ema.europa.eu/en/documents/herbal-monograph/draft-european-union-herbal-monograph-arnica-montana-l-flos_en.pdf
  31. Committee on Herbal Medicinal Products (2014). Assessment report on Arnica montana L., flos (EMA/HMPC/198794/2012). European Medicines Agency. https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-arnica-montana-l-flos_en.pdf
  32. NC State Extension (n.d.). Arnica montana (leopard’s-bane). North Carolina Extension Gardener Plant Toolbox. https://plants.ces.ncsu.edu/plants/arnica-montana/

From the Journal

View all articles →